Yusuke Miyazaki

Jan 20, 2025 | lupus.bmj.com | Yoshiya Tanaka |Yusuke Miyazaki |Shintaro Hirata |Katsuhide Kusaka

In clinical practice, a lupus low disease activity state (LLDAS) has been proposed as an alternative treatment target for patients with SLE. LLDAS is associated with reduced accrual of organ damage and improvements in quality of life. Patients with SLE in LLDAS experienced a residual disease burden, especially in pain and fatigue, that was associated with activity impairment.

Oct 4, 2024 | ard.bmj.com | Satoshi KUBO |Yusuke Miyazaki |Takahiro Nishino |Yuya Fujita

Peripheral blood immunophenotypic diversity in patients with rheumatoid arthritis and its impact on therapeutic responsiveness Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Feb 3, 2024 | pubs.acs.org | Yusuke Miyazaki |Kenichi Michigami |Masato Ohashi

CCDC 2312313–2312319 contain the supplementary crystallographic data for this paper. These data can be obtained free of charge via www.ccdc.cam.ac.uk/data_request/cif, or by emailing [email protected], or by contacting The Cambridge Crystallographic Data Centre, 12 Union Road, Cambridge CB2 1EZ, UK; fax: +44 1223 336033. Terms & Conditions Most electronic Supporting Information files are available without a subscription to ACS Web Editions.

Jan 11, 2024 | ard.bmj.com | Hiroaki Tanaka |Yukinori Okada |Shingo Nakayamada |Yusuke Miyazaki

IntroductionAutoimmune rheumatic diseases (AIRDs) are systemic diseases characterised by orchestration of disrupted self-tolerance of immune systems, including rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE).1 2 Given shared immunological backgrounds across AIRDs, glucocorticoid and immunosuppressive drugs have been conventionally used for treatment.

Oct 30, 2023 | ard.bmj.com | Hiroaki Tanaka |Yukinori Okada |Shingo Nakayamada |Yusuke Miyazaki

DiscussionsIn this study, we evaluated the large-scale and cohort-based immunophenotype dataset over 1000 individuals and 11 AIRDs with deep and longitudinal clinical information.